Microbix Biosystems granted U.S. patent for its influenza vaccine yield enhancement technology
Microbix Biosystems Inc. has been granted a patent by the U.S. Patent Office for its technology - VIRUSMAX(TM) - which enables vaccine manufacturers to double the amount of influenza vaccine they produce each year.
According to the company, Microbix' discovery has enormous implications for protecting more people during a pandemic. Patents are also being allowed in Canada, India and Australia, and a number of other applications in major markets are currently pending.
"We're delighted that we now have strong patent protection as we engage in assisting manufacturers increase production" said William J. Gastle, CEO of Microbix. The company's technology will be licensed to manufacturers on a non-exclusive basis.
VIRUSMAX(TM) can be implemented quickly and cost-effectively by manufactures, allowing them to ramp up production in a matter of months. Microbix has established a Special Workgroup for Applied Technology Transfer (SWATT) to help manufacturers adopt the process. The SWATT team is now being sent to various facilities to assist customers in implementing the technology and training local personnel.
Most read news
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
AMRI Promotes Takeshi Yura, Ph.D., to Vice President of Discovery and Development Services, Asia
